Basilea grants Pfizer European license to Cresemba; rights now include China and Asia Pacific
Basilea Pharmaceutica Ltd. licensed Pfizer Inc. exclusive rights to commercialize and distribute the antifungal Cresemba (isavuconazole) in European countries including Austria, France, Germany, Italy, and the UK, all territories where the drug is already being sold.
- Includes Royalty or Profit Split Information
- Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com